Catalyst Biosciences Inc (CBIO) Down 8.96% in Premarket Trading

Wednesday, May 25, 2022 06:45 AM | InvestorsObserver Analysts

Mentioned in this article

Catalyst Biosciences Inc (CBIO) Down 8.96% in Premarket Trading

Catalyst Biosciences Inc (CBIO) has fallen Wednesday morning, with the stock falling -8.96% in pre-market trading to 1.22. CBIO's short-term technical score of 95 indicates that the stock has traded more bullishly over the last month than 95% of stocks on the market. In the Biotechnology industry, which ranks 133 out of 146 industries, CBIO ranks higher than 98% of stocks. Catalyst Biosciences Inc has risen 131.03% over the past month, closing at $0.52 on April 27. During this period of time, the stock fell as low as $0.36 and as high as $1.47. CBIO has an average analyst recommendation of Strong Buy. The company has an average price target of $9.00.

CBIO has an Overall Score of 90. Find out what this means to you and get the rest of the rankings on CBIO!

See Full CBIO Report

Catalyst Biosciences Inc has a Long-Term Technical rank of 89. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 11% of the market scoring higher. In the Biotechnology industry which is number 139 by this metric, CBIO ranks better than 139% of stocks.

Important Dates for Investors in CBIO:

-Catalyst Biosciences Inc is set to release earnings on 8/7/2022. Over the last 12 months, the company has reported EPS of $-2.54. -We do not have a set dividend date for Catalyst Biosciences Inc at this time. Click Here To Get The Full Report on Catalyst Biosciences Inc (CBIO)